A smartphone app allowing Parkinson’s disease patients to report their day-to-day symptoms is a reliable tool for improving communication with doctors, a study found. Patients’ self-assessments using the Parkinson’s Image Self Report generally aligned with doctors’ clinical ratings, the researchers said. “Integration with wearables and telemedicine may advance patient-centered [Parkinson’s]…

Spinal cord stimulation appears to be safe and may help people with Parkinson’s disease maintain movement, although it did not improve posture, balance, or gait compared with sham treatment in a small study from Denmark. The STEP-PD study (NCT05110053) involved 12 patients with gait impairments who were randomly…

Targeting a brain network that links thinking and movement may be an effective treatment strategy for easing motor symptoms in people with Parkinson’s disease. The somato-cognitive action network (SCAN) lies within the motor cortex, a brain region that controls body movements. In Parkinson’s, SCAN dysfunction, particularly increased connectivity between…

The University of Southern California’s Keck School of Medicine is recruiting patients for a Phase 1 clinical trial evaluating RNDP-001, an experimental cell replacement therapy being developed by Kenai Therapeutics for moderate to severe Parkinson’s disease. The company-sponsored REPLACE (NCT07106021), which began dosing late last year,…

Merz Therapeutics North America has launched “Celebrating the Fighters,” a nationwide U.S. community campaign honoring the resiliency and courage of people with Parkinson’s disease. The campaign features several initiatives, including a national TV ad, and offers social media and advocacy resources. It leverages the resilience and spirit of…